Effect of the antidiabetic agent pioglitazone on bone metabolism in rats

• Үндсэн зохиолчид: Junkichi Kanda (Зохиогч), Nobuo Izumo (Зохиогч), Yoshiko Kobayashi (Зохиогч), Kenji Onodera (Зохиогч), Taketoshi Shimakura (Зохиогч), Noriaki Yamamoto (Зохиогч), Hideaki E. Takahashi (Зохиогч), Hiroyuki Wakabayashi (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2017-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Thiazolidinediones (TZDs) are synthetic peroxisome proliferator-activated receptor gamma (PPARγ) agonists used as therapy for type 2 diabetes. However, clinical studies reported that the therapeutic modulation of PPARγ activity using TZDs may induce negative effects on bone metabolism. This study ai...